Clinical studies have demonstrated an increasing number of cells positive for p16 and β-galactinase-related markers of aging in the coronary media and increased expression of Runx2 in patients with CKD, that is, the co-phenotype of vascular aging and VC [53]. The gene discussed is RUNX2; the disease is chronic kidney disease.